Results 101 to 110 of about 302,737 (317)

The AD/HD family support group [PDF]

open access: yes, 2004
Attention Deficit Hyperactivity Disorder is still a diagnosis which raises many questions.
Anastasi, Tessa
core  

Complexity Analysis of Spontaneous Brain Activity in Attention-Deficit/Hyperactivity Disorder: Diagnostic Implications [PDF]

open access: yes, 2009
Background: Attention-deficit/hyperactivity disorder (ADHD) is defined as the most common neurobehavioral disorder of childhood, but an objective diagnostic test is not available yet to date.
Aboy   +56 more
core   +3 more sources

Understanding Inequality Within a Personalised System of Disability Support: Australian Children With Disabilities' Unmet Support Needs

open access: yesAustralian Journal of Social Issues, EarlyView.
ABSTRACT Disability support has shifted towards models of personalised care, which critics argue may contribute to increased inequalities. There is limited systematic evidence investigating inequalities in support among children with disabilities. To investigate inequalities in support, a survey of parents of children with disabilities aged 2–17 was ...
Martin O'Flaherty   +2 more
wiley   +1 more source

The measurement of the symptoms of ADHD in the NICHQ Vanderbilt Assessment Scale for Parent (VADPRS) and for Teacher (VADTRS)

open access: yesPsychiatria i Psychologia Kliniczna, 2014
The presence of several inattentive or hyperactive, impulsive symptoms in two or more situations (at home, school, in other activities) is required for the diagnosis of attention deficit hyperactivity disorder. There is clear evidence that the symptoms
Halina Kądziela-Olech
doaj   +1 more source

Características del trastorno por déficit de atención con hiperactividad [PDF]

open access: yes, 2016
This paper presents a brief review of different aspects concerning Attention Deficit Hyperactivity Disorder (ADHD): core symptoms, evolution from childhood to adulthood, prevalence, comorbidity, diagnostic criteria and treatment history.
Amador, Juan Antonio   +2 more
core  

From clinical application to cognitive enhancement: the example of methylphenidate [PDF]

open access: yes, 2016
Methylphenidate (MPD) is a central nervous system (CNS) stimulant, which belongs to the phenethylamine group and is mainly used in the treatment of attention deficit hyperactive disorder (ADHD).
Busardo', FRANCESCO PAOLO   +4 more
core   +1 more source

Multimorbidity and animal models

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Multimorbidity, defined as the coexistence of ≥2 chronic conditions, is associated with aging, genetics, and environmental factors. Animal models in multimorbidity research span three tiers: simple organisms for initial screening → rodents for mechanistic analysis → large mammals for clinical prediction.
Xinpei Wang   +7 more
wiley   +1 more source

Late Pregnancy Antiseizure Medication Exposure and Offspring Neurodevelopmental Risk: A Multi‐Child Cohort Study

open access: yesAnnals of Neurology, EarlyView.
Objective Antiseizure medication (ASM) use during pregnancy has increased over the past decade. However, evidence linking prenatal ASM exposure to neurodevelopmental disorders (NDDs) in offspring remains inconsistent. This study evaluated whether prenatal ASM exposure increases the risk of NDDs in children.
Odile Sheehy   +13 more
wiley   +1 more source

A review of the economic burden of ADHD [PDF]

open access: yes, 2005
Attention-deficit hyperactivity disorder (ADHD) is a common disorder that is associated with broad functional impairment among both children and adults.
Matza, Louis S   +2 more
core   +2 more sources

Drugs induced Raynaud's phenomenon and underlying mechanism: a disproportionality analysis from the WHO pharmacovigilance database

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's Phenomenon (RP) and to explore their potential pathophysiological mechanisms through a mixed disproportionality/clustering analysis from the WHO pharmacovigilance database.
Alex Hlavaty   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy